The synthetic DNA maker Twist Bioscience announced at the J.P. Morgan Health Care Conference earlier this month that it is developing enzymatic DNA synthesis technology. The revelation—by a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback